ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says

March 11, 1977

Bush Proposes $27.9 Billion for NIH, Plus $1.4B Reprogram From FY03

February 7, 2003

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

Litton’s Government Contracts Status Under Review

September 6, 1985

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000

Impath Buys Clinical Studies Support Services Network.

September 28, 2001